title: [Renal involvement in patients with chronic inflammatory intestinal disease treated with mesalazine. How to prevent its nephrotoxicity?].
authors.forename: J
authors.initials: J
authors.lastname: Bonet
authors.forename: M
authors.initials: M
authors.lastname: Vaquero
authors.forename: B
authors.initials: B
authors.lastname: Bayés
authors.forename: R
authors.initials: R
authors.lastname: Romero
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008297:Male; D019804:Mesalamine / Q000009:adverse effects*; D009395:Nephritis, Interstitial / Q000139:chemically induced
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine